Nova Financial LLC: GSK position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Nova Financial LLC on GSK, newest first. How the timeline and the estimate are built.
Nova Financial LLC held 640 GSK shares at 2026-09-30 per its 13F-HR filed 2026-11-04.
the latest 13F is the newest step
- period ended2026-09-3013F 640 sharesChange vs previous 13F 0 shares
0.01% of the 13F portfolio, value $30,829.
13F-HR 0002158449-26-000001 filed by Nova Financial LLC
Accepted , ingested - period ended2026-06-3013F 640 sharesChange vs previous 13F -140 shares
0.01% of the 13F portfolio, value $33,549.
13F-HR 0002158449-26-000002 filed by Nova Financial LLC
Accepted , ingested - period ended2026-03-3113F 780 sharesChange vs previous 13F 0 shares
0.02% of the 13F portfolio, value $43,049.
13F-HR 0002158449-26-000003 filed by Nova Financial LLC
Accepted , ingested - period ended2025-12-3113F 780 sharesChange vs previous 13F +2 shares
0.02% of the 13F portfolio, value $38,252.
13F-HR 0002158449-26-000004 filed by Nova Financial LLC
Accepted , ingested - period ended2025-09-3013F 778 sharesChange vs previous 13F +2 shares
0.02% of the 13F portfolio, value $33,565.
13F-HR 0002158449-26-000005 filed by Nova Financial LLC
Accepted , ingested - period ended2025-06-3013F 776 sharesChange vs previous 13F +4 shares
0.02% of the 13F portfolio, value $29,790.
13F-HR 0002158449-26-000006 filed by Nova Financial LLC
Accepted , ingested - period ended2025-03-3113F 772 sharesChange vs previous 13F -129 shares
0.02% of the 13F portfolio, value $29,913.
13F-HR 0002158449-26-000007 filed by Nova Financial LLC
Accepted , ingested - period ended2024-12-3113F 901 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $30,462.
13F-HR 0002158449-26-000008 filed by Nova Financial LLC
Accepted , ingested